ArticleNature communications2021
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
Yundong He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this paperpooled ittrialcites it